z-logo
open-access-imgOpen Access
Safety and Efficacy of Rivaroxaban When Added to Aspirin Monotherapy Among Stabilized Post‐Acute Coronary Syndrome Patients: A Pooled Analysis Study of ATLAS ACS‐TIMI 46 and ATLAS ACS 2‐TIMI 51
Author(s) -
Gibson William J.,
Gibson C. Michael,
Yee Megan K.,
Korjian Serge,
Daaboul Yazan,
Plotnikov Alexei N.,
Burton Paul,
Braunwald Eugene
Publication year - 2019
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.118.009451
Subject(s) - medicine , timi , rivaroxaban , acute coronary syndrome , aspirin , myocardial infarction , cardiology , clinical endpoint , coronary artery disease , thrombolysis , randomized controlled trial , warfarin , atrial fibrillation

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom